Drug intelligence / Profile preview

Neosalus

Development stage
Unknown
Lead developer
Quinnova Pharmaceuticals
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems
Administration
Topical
01

Overview

Neosalus is a prescription, nonsteroidal topical dermatologic product line (cream, lotion, and foam) that uses a patented water–lipid Proderm Technology to provide skin barrier repair, protection, and hydration in patients with various dermatoses, including atopic dermatitis and allergic contact dermatitis.[1][2][4][6] The formulations are classified pharmacologically as nonsteroidal antipruritics/skin protectant dressings and contain excipient-type ingredients such as dimethicone to reduce transepidermal water loss, glycerin as a humectant, and stearic/palmitic acids to support ceramide and lipid production in the stratum corneum.[1][2][3][4] Neosalus received US FDA clearance in 2008–2009 as a prescription water-soluble dressing for the management and relief of irritation and inflammation associated with a variety of skin conditions, and is marketed primarily for chronic eczematous dermatoses as a steroid-sparing therapy with favorable cosmetic properties.[2][3][5][6][13][15]

Brand names
Neosalus

Beyond the preview

Go deeper on Neosalus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neosalus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call